<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>COMPANIES ELIGIBLE FOR APPROVAL</title>
    <link>https://www.taxtmi.com/acts?id=44592</link>
    <description>Companies applying for approval of the Prescribed Authority must have well defined, documented R&amp;D programmes, valid DSIR recognition, separate earmarked R&amp;D premises with exclusive R&amp;D staff, and separate audited accounts reporting capital and recurring R&amp;D expenditures; eligibility is confined to biotechnology or manufacturing businesses not producing items specified in the Eleventh Schedule.</description>
    <language>en-us</language>
    <pubDate>Tue, 08 Oct 2024 14:58:29 +0530</pubDate>
    <lastBuildDate>Tue, 08 Oct 2024 14:58:29 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=772157" rel="self" type="application/rss+xml"/>
    <item>
      <title>COMPANIES ELIGIBLE FOR APPROVAL</title>
      <link>https://www.taxtmi.com/acts?id=44592</link>
      <description>Companies applying for approval of the Prescribed Authority must have well defined, documented R&amp;D programmes, valid DSIR recognition, separate earmarked R&amp;D premises with exclusive R&amp;D staff, and separate audited accounts reporting capital and recurring R&amp;D expenditures; eligibility is confined to biotechnology or manufacturing businesses not producing items specified in the Eleventh Schedule.</description>
      <category>Act-Rules</category>
      <law>Direct Taxes</law>
      <pubDate>Tue, 08 Oct 2024 14:58:29 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/acts?id=44592</guid>
    </item>
  </channel>
</rss>